Hans‐Peter Brunner‐La Rocca

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer, Stefan D. Anker, Javed Butler et al. · New England Journal of Medicine · 2020 · 5K citations · Full text

Medicine, Cardiology, Pharmacology +17

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker, Javed Butler, Gerasimos Filippatos et al. · New England Journal of Medicine · 2021 · 4.6K citations · Full text

Medicine, Cardiology, Pharmacology +14

Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents

Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca, Peter Buser et al. · Journal of the American College of Cardiology · 2006 · 1.3K citations

Medicine, Cardiology, Pharmacotherapy +15

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +6

BNP-Guided vs Symptom-Guided Heart Failure Therapy

Matthias Pfisterer, Peter Buser, Hans Rickli et al. · JAMA · 2009 · 644 citations

Medicine, Cardiology, Internal Medicine +15